The FDA has approved Evolysse Form and Evolysse Smooth injectable hyaluronic acid gels, two dermal fillers from Evolus, the ...
By Christy Santhosh (Reuters) -Evolus said on Thursday the U.S. drug regulator has approved its two new anti-wrinkle gels, expanding the company's product portfolio beyond its cosmetic injection ...
Evolus Inc . (NASDAQ:EOLS), a company specializing in aesthetic products with a market capitalization of $933 million, has recently made significant strides in expanding its product portfolio and ...
Evolus, Inc. has announced FDA approval for two new injectable hyaluronic acid gels, Evolysse Form and Evolysse Smooth. These ...
Evolus Announces FDA Approval of Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels
In the head-to-head clinical study versus Restylane-L, the safety profile ... further expanding Evolus’ footprint into the global dermal filler market and reinforcing its position as a leader ...
Evolus Announces FDA Approval of Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels
First Major Technological Breakthrough in Hyaluronic Acid Dermal Fillers in a Decade; U.S. Launch Planned in Q2 2025 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback